Cidara Therapeutics Announces First Subjects Dosed in Phase 2b NAVIGATE Trial Evaluating CD388 for the Prevention of Seasonal Influenza
September 23, 2024 08:00 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC)...
Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress
September 23, 2024 08:00 ET
|
Intra-Cellular Therapies Inc.
Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) Poster...
Monster Digital Adds Significant Digital Production Capacity with the Adoption of 10 Additional Kornit Apollo Systems During 2025
September 23, 2024 08:00 ET
|
Kornit Digital Ltd
On demand manufacturer serves the world’s largest global brands, retailers and e-commerce platformsOperates three locations, nearshore and onshore, running 24/7, promoting new product delivery and...
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor Candidate ABI-5366
September 23, 2024 08:00 ET
|
Assembly Biosciences, Inc.
– ABI-5366 was well-tolerated, with a favorable safety profile observed with exposure of up to 70 days – – Half-life of approximately 20 days supports once-weekly or once-monthly oral dosing; both...
OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development
September 23, 2024 08:00 ET
|
OPKO Health, Inc.
WESTON, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health, Inc. (NASDAQ: OPK) company, today announced the appointment of Giovanni Abbadessa, M.D., Ph.D. as Chief...
Actuate Announces Scientific Reports Publication on Elraglusib’s Novel Immunomodulatory Mechanism of Action as a GSK-3β Inhibitor
September 23, 2024 08:00 ET
|
Actuate Therapeutics
New Mechanistic Insights Underscore Multiple Potential Roles for Elraglusib as an Immune Modulator in the treatment of NeuroblastomaStudy Illustrates Potential to Activate the Immune System Even in...
Kratos SRE Welcomes Congressman Gary Palmer to Facility in Birmingham
September 23, 2024 08:00 ET
|
Kratos Defense & Security Solutions, Inc.
SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in Defense, National Security and Global Markets, recently...
Icon Energy Corp. Announces the Delivery of M/V Bravo and the Signing of a Term Loan Facility for up to $91.5 million
September 23, 2024 08:00 ET
|
Icon Energy Corp.
ATHENS, Greece, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Icon Energy Corp. (“Icon” or the “Company”) (Nasdaq: ICON), an international shipping company that provides worldwide seaborne transportation...
Solid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines Conference
September 23, 2024 08:00 ET
|
Solid Biosciences Inc.
CHARLESTOWN, Mass., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for...
Xunlei Announces Appointment of Two New Directors
September 23, 2024 08:00 ET
|
Xunlei Limited
SHENZHEN, China, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading technology company providing distributed cloud services in China, today...